Yijia Wang is a Medical Director in Late Development at Pfizer, a position held since 2025. Previously, Yijia served as a Clinical Science Director and Associate Director in Clinical Development at Exelixis, and held various roles in clinical development at AROG Pharmaceuticals, Inc. and Columbia University Medical Center. Yijia obtained a Bachelor's and Master's degree in Medicine from Shanghai Jiao Tong University, certified by WES, and a Master of Public Health in Epidemiology from The University of Texas Health Science Center at Houston. Earlier experiences include roles at MD Anderson Cancer Center and the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices